PubMed Health⌕ Search

Biomedical subjects

E Gargano

Publications and source records attributed to E Gargano.

At least 19 recordsLinked to original sources
PubMed2003

[Solid pseudopapillary tumour of the pancreas. Report of a case].

Solid pseudopapillary pancreatic tumour is an uncommon disease including 2.7% of exocrine malignancies of the pancreas. Its low incidence is associated with an uncertain prognosis and with difficult diagnostic and therapeutic problems, despite routine use of ultrasonography, TC and RMN. A case of solid pseudopapillary pancreatic tumour in a young woman is reported: the clinicopathologic features, diagnostic imaging and surgical treatment are discussed. Surgery is the primary option. Prognosis is however not fully known. From a review of the literature it is suggested that these tumours should be regarded as potentially malignant.

Adult↗
PubMed2000

Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer.

Matrix metalloproteinases (MMP) are members of a multigene family of zinc-dependent enzymes involved in the degradation of extracellular matrix components. Cancer research suggest that MMP and tissue inhibitors of metalloproteinases (TIMP) may be involved in disease progression; these enzymes could therefore be used as markers in cancer prevention programmes and for clinical monitoring. To establish whether MMP and TIMP can be used effectively as markers we determined serum levels of MMP1 and TIMP1, and studied the relationships between these enzymes and the stage of disease. The potential diagnostic and prognostic value of serum level measurements of MMP1 and TIMP1 was evaluated by comparing them with serum levels of soluble carcinoembryonic antigens (sCEA) and p53 antibodies. Our overall results indicate that simultaneous measurements of serum sCEA and TIMP1 in patients with colorectal cancer could be used as prognostic and diagnostic markers for disease progression from the pre-invasive nodal phase to the invasive phase (stages I, II to III, IV). In addition, serum levels of TIMP1 could be used as a selective marker for metastatic disease (stage III to IV). In fact, the 95% confidence interval of the serum levels of sCEA at stage III (18.4 < or = sCEA < or = 68.6 ng/ml) and TIMP1 at stage IV (1620 < or = TIMP1 < or = 3906 ng/ml) identified statistically significant ranges of values (sCEA P = 0.02, TIMP1 P = 0.02), which may be useful in the monitoring of patients at these disease phases. More specifically, our data suggest that, when the serum level of sCEA is below 18.4 ng/ml and the level of TIMP1 below 1620 ng/ml, there is a 95% probability that the disease is in the pre-invasive nodal phase; when the serum level of sCEA falls between 18.4 ng/ml and 68.6 ng/ml and the level of TIMP1 is below 1620 ng/ml, there is a 95% probability that the disease is in the phase when lymph node infiltration occurs; when the level of sCEA is above 68.6 ng/ml and the level of TIMP1 is at least 1620 ng/ml, there is a 95% probability that the disease is in the metastatic phase.

Adult↗
PubMed1985

[Breast cancer. Epidemiology and other factors related to incidence in various populations].

An extensive review of epidemiology, etiology, age, genetic factors, race, alimentary habits and hormonal patterns have been analysed in studies concerning patients with breast cancer. The role of other factors (the age of menopause, the geographic distribution, the action of reserpine and many possible causes) are also discussed. The evidences observed in many studies performed in the last years in different countries are compared but definitive data cannot be reached. The material reported in these studies is not homogeneous and this review can only indicate the problems still present in this field and the subjects we need to investigate in the next years.

Age Factors↗
PubMed1980

[Cancer of the colon and rectum in young people].

A review of surgical treatment for cancer of the colon and rectum has shown that 5 of 87 patients were younger than 30 years old. The symptoms were abdominal pain and anemia and were present about 2 years before the hospital admission. The survival after the surgical treatment was, for all patients, 11 months.

Adenocarcinoma↗
PubMed1979

[Transplantation of the kidney in the rat. I. Problems of surgical technic].

Is described a technique for transplanting rat kidneys. The technique involves suture of vessels of less than 1 mm in diameter with microsurgical techniques. Were used adult male rats of wistar strain. The kidney is perfused with 250 cc of ringer lactate, heparin 10.000 U.I., solumedrol 1 g novocain 150 mg. The results were very good.

Animals↗
PubMed1979

[Metabolic changes after extended hepatic resection].

Two cases of right hepatic lobe resection, one due to trauma and the other to echinococcosis. Adequate support therapy can be used to control the protein, lipid and sugar metabolic changes that occur after this operation. The seriousness of the postoperative course is related to the amount of healthy tissue removed.

Adult↗